Pegasus Partners Ltd. Eli Lilly & CO Transaction History

Pegasus Partners Ltd.

  • $1.07 Billion
  • Q3 2024

A detailed history of Pegasus Partners Ltd. transactions in Eli Lilly & CO stock. As of the latest transaction made, Pegasus Partners Ltd. holds 1,516 shares of LLY stock, worth $1.21 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
1,516
Previous 1,403 8.05%
Holding current value
$1.21 Million
Previous $1.27 Million 5.75%
% of portfolio
0.13%
Previous 0.13%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024
BUY
$772.14 - $960.02 $87,251 - $108,482
113 Added 8.05%
1,516 $1.34 Million
Q2 2024

Aug 07, 2024
BUY
$724.87 - $909.04 $147,873 - $185,444
204 Added 17.01%
1,403 $1.27 Million
Q1 2024

Apr 24, 2024
BUY
$592.2 - $792.28 $6,514 - $8,715
11 Added 0.93%
1,199 $932,000
Q4 2023

Feb 12, 2024
SELL
$525.19 - $619.13 $29,410 - $34,671
-56 Reduced 4.5%
1,188 $692,000
Q3 2023

Nov 13, 2023
BUY
$434.7 - $599.3 $4,781 - $6,592
11 Added 0.89%
1,244 $668,000
Q2 2023

Aug 04, 2023
SELL
$350.74 - $468.98 $30,865 - $41,270
-88 Reduced 6.66%
1,233 $578,000
Q1 2023

May 10, 2023
BUY
$310.63 - $364.82 $27,335 - $32,104
88 Added 7.14%
1,321 $453,000
Q3 2022

Nov 10, 2022
SELL
$296.48 - $337.87 $5,929 - $6,757
-20 Reduced 1.6%
1,233 $399,000
Q2 2022

Aug 12, 2022
BUY
$278.73 - $327.27 $5,574 - $6,545
20 Added 1.62%
1,253 $406,000
Q1 2022

May 13, 2022
SELL
$234.69 - $291.66 $41,540 - $51,623
-177 Reduced 12.55%
1,233 $353,000
Q4 2021

Feb 09, 2022
BUY
$224.85 - $279.04 $317,038 - $393,446
1,410 New
1,410 $389,000
Q1 2018

May 09, 2018
SELL
$74.21 - $87.6 $1.05 Million - $1.24 Million
-14,174 Closed
0 $0
Q4 2017

Feb 08, 2018
SELL
$81.94 - $87.89 $478,529 - $513,277
-5,840 Reduced 29.18%
14,174 $1.2 Million
Q3 2017

Nov 09, 2017
BUY
$77.07 - $85.54 $1.54 Million - $1.71 Million
20,014
20,014 $1.71 Million

Others Institutions Holding LLY

# of Institutions
4,011
Shares Held
751M
Call Options Held
8.27M
Put Options Held
10.5M
View Full List

About ELI LILLY & Co

LLY Quotes by TradingView
  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Pegasus Partners Ltd. Portfolio

Follow Pegasus Partners Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pegasus Partners Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Pegasus Partners Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email